Mayne Pharma CEO Steps Down Amid $475m Metrics Contract Services Sale
CEO’s Departure Marks Turning Point For Mayne Pharma
Significant change is brewing at Mayne Pharma, with the Australian firm announcing the proposed sale of its US-based CDMO business for nearly half-a-billion dollars. At the same time, long time CEO Scott Richards is heading for the exit door.
